ADPT financials
Adaptive Bio (ADPT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ADPT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $276.98M | $205.62M | -$57.12M | -$59.50M | -0.39 |
| 2024 | $178.96M | $106.88M | -$162.55M | -$159.49M | -1.08 |
| 2023 | $170.28M | $94.72M | -$227.03M | -$225.25M | -1.56 |
| 2022 | $185.31M | $127.40M | -$200.19M | -$200.19M | -1.00 |
| 2021 | $154.34M | $105.04M | -$208.97M | -$207.28M | -1.46 |
| 2020 | $98.38M | $75.85M | -$152.82M | -$146.23M | -1.06 |
- ADPT revenue was $276.98M in fiscal 2025, net income -$59.50M.
Updated 2026-11-03 00:09 UTC